BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  Nanophase Technologies Corporation Reports Fourth Quarter And Year End 2013 Financial Results

  February 27, 2014

   · 

  1 min read
• Biotech Beach

  MRI Interventions, Inc.’ Cleartrace System To Be Featured In Presentation At The 2014 Western Atrial Fibrillation Symposium

  February 27, 2014

   · 

  1 min read
• Drug Development

  QLT Inc. Announces Positive Preliminary Results From Phase 1b Retreatment Trial Of QLT091001 In Subjects With Leber Congenital Amaurosis And Retinitis Pigmentosa Due To Mutations In LRAT Or RPE65

  February 27, 2014

   · 

  1 min read
• ALK-Abello A/S Participates In The Credit Suisse 2014 London Healthcare Conference

  February 27, 2014

   · 

  1 min read
• Royal DSM Resumes Repurchase Of Shares To Cover Existing Option Plans

  February 27, 2014

   · 

  1 min read
• Prima Biomed To Present At Regen Med Investor Day March 26th In New York

  February 27, 2014

   · 

  2 min read
• BioLight Life Sciences To Present At 26th Annual ROTH Conference

  February 27, 2014

   · 

  1 min read
• Drug Development

  Sinovac Biotech Ltd.'s EV71 Vaccine Phase III Clinical Trial Results Published In The New England Journal of Medicine

  February 27, 2014

   · 

  7 min read
• Policy

  Forest Laboratories, Inc. Submits A New Drug Application For Nebivolol And Valsartan Combination In Hypertension

  February 27, 2014

   · 

  1 min read
• Pharm Country

  European Medicines Agency Accepts Marketing Authorization Application For The Medicines Company’s Oritavancin

  February 27, 2014

   · 

  3 min read